October 20 & 21, 2021
Columbia Metropolitan Convention Center
1101 Lincoln Street
Columbia, South Carolina 29201
Date: Oct 20, 2021 10:40 AM - Oct 21, 2021 12:50 PM
CE Hours
CE Units
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacists
Accreditation(s)
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Co-Sponsor(s)
Requirements for CE Credit
- Identify viral suppression trends for people living with HIV (PLWH) using Medicaid
- Describe retention in care trends for PLWH using Medicaid
- Recognize mortality trends for PLWH using Medicaid
Speaker(s)/Author(s)
Tony Brown, MPH
|
Activity Number
0062-9999-21-137-L02-PCE Hours
- Review current treatment and prevention guideline recommendations for HIV
- Review new medications for HIV
- Review top research findings in HIV
Speaker(s)/Author(s)
Sharon Weissman, MD
|
Activity Number
0062-9999-21-138-L02-PCE Hours
- Discuss the latest Hepatitis C screening and testing recommendations
- Review Hepatitis C lab interpretation
- Discuss the Hepatitis C Treatment Guidelines including the simplified algorithm
Speaker(s)/Author(s)
Divya Ahuja, MD, MRCP (London)
|
Activity Number
0062-9999-21-139-L01-PCE Hours
- Explain the importance of HIV PrEP-to-need ratios (PnRs) and the variability in HIV PnRs among counties in South Carolina
- Discuss associations identified between HIV PnRs and literacy rates at the county level in South Carolina
- Analyze strategies to improve HIV PnRs among underrepresented counties in South Carolina
Speaker(s)/Author(s)
Kenric Ware, PharmD, MBA, AAHIVP
|
|
Mia Turner, PharmD Candidate 2022
|
Activity Number
0062-9999-21-140-L02-PCE Hours
- Apply current recommendations regarding cabotegravir and rilpivirine long-acting injectable for the treatment of HIV
- Summarize the efficacy and safety of cabotegravir and rilpivirine long-acting injectable for HIV treatment
- Describe the workflow of implementing cabotegravir and rilpivirine long-acting injectable into real-world practice
Speaker(s)/Author(s)
Morgan Pizzuti, PharmD
|
|
Y. Vivian Tsai, PharmD
|
Activity Number
0062-9999-21-141-L02-PCE Hours
- Describe emerging treatment options for HIV infected individuals
- Apply barriers to use of these agents in clinical practice to a real patient case
- Outline prevention strategies on the horizon for HIV
Speaker(s)/Author(s)
Caroline Derrick, PharmD, BCPS, AAHIVP
|